Francisco José López Jaime, MD

Hematologist
Hemostasis and Thrombosis Unit, Regional University Hospital of Málaga, IBIMA, Málaga, Spain.

Francisco J. López Jaime, MD, works at University Hospital Regional of Málaga (Spain).
He is a specialist in Hemostasis and Thrombosis.
He participates as principal investigator in more than 20 clinical trials, including gene therapy and non-replacement drugs for hemophilia patients, such as emicizumab, concizumab or MIM8.
He actively participates in training for patients and families.

Presentation(s):

• OC 40.1 - FRONTIER1: A Phase 1/2 Dose Escalation Study of a Novel Factor VIIIa Mimetic Bispecific Antibody, Mim8, for Evaluation of Safety, Pharmacokinetics, and Efficacy

  Monday, July 11, 2022
  2:45 PM – 3:00 PM

• OC 50.5 - Mim8 is associated with improved thrombin generation vs. emicizumab in patients with haemophilia A, with and without inhibitors

  Tuesday, July 12, 2022
  11:45 AM – 12:00 PM

• PB1136 - An Observational Study To Evaluate The Impact And Disease Burden In Moderate And Severe Hemophilia From Nursing And Patient Perspective (Study Nurses-Who-Care / ML42270)

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM